News Incyte shares down sharply after phase 3 skin cancer trial f... Trial tested epacadostat pill in combination with Merck & Co’s Keytruda
Views & Analysis Digital health round-up: Blockchain, digital disruption and ... Richard Staines presents a weekly round-up of the latest developments in digital health
News IT playing key role in England's new cancer diagnosis centre... A series of cancer diagnosis 'one-stop shops' is being rolled out across England, with digital health technology playing an important role in hastening diagnosis.
News 'Sugar tax' already working, say health campaigners Many drinks manufacturers have changed recipes to avoid tax
News Gilead strikes again, penning $5bn deal to buy Tubulis Gilead has signed its third acquisition deal since the start of the year, agreeing to buy ADC specialist Tubulis for $3.15bn upfront.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
